BioAesthetics Announces Additional Clinical Study for NACgraft
NACgraft Aims to Improve Quality-of-Life for Breast Cancer Patients RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–BioAesthetics Corporation today announced an additional clinical study for the BioAesthetics® NACgraft™ Acellular Allograft that will investigate its performance in subpopulations of breast cancer survivors and other individuals needing nipple reconstruction. The previously announced study at Stanford Medicine focuses on female breast … [Read more…]
